KYNTRA BIO, INC. (KYNB) stock: key figures, P/E, revenue and dividend
Health Care · United States · ISIN US31572Q8814
KYNTRA BIO, INC. financials
| Fiscal year | 2025 |
|---|---|
| Revenue | 6.44 m USD |
| Gross profit | 5.88 m USD |
| Operating income | -45.90 m USD |
| EBIT | 192.12 m USD |
| Net income | 183.45 m USD |
| Diluted EPS – continuing operations | 45.37 USD |
Full history since 2012, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About KYNTRA BIO, INC.
Kyntra Bio, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. The company is developing FG-3246, a potential antibody-drug conjugate targeting CD46, for the treatment of metastatic castration-resistant prostate cancer and other cancers. It is also developing Roxadustat, a small molecule inhibitor of hypoxia-inducible factor prolyl hydroxylase activity, which has completed Phase III clinical development for the treatment of anemia in chronic kidney disease in the United States, Europe, Japan, and other countries, as well as in Phase III clinical development for anemia related with myelodysplastic syndromes. The company has collaboration agreements with Astellas Pharma Inc. and AstraZeneca AB. The company was formerly known as FibroGen, Inc. and change its name to Kyntra Bio, Inc. in January 2026. Kyntra Bio, Inc. was incorporated in 1993 and is headquartered in San Francisco, California.
More stocks
- Norris Industries, Inc. (NRIS)
- Galenfeha, Inc. (NGHI)
- PACIFIC HEALTH CARE ORGANIZATION INC (PFHO)
- Hepion Pharmaceuticals, Inc. (HEPA)
- Bionano Genomics, Inc. (BNGO)
- SunPower Inc. (SPWR)
- Inhibitor Therapeutics, Inc. (INTI)
- Neuphoria Therapeutics Inc. (NEUP)
- KEEMO Fashion Group Ltd (KMFG)
- MDxHealth SA (MDXH)
- Virtuix Holdings Inc. (VTIX)
- Good Times Restaurants Inc. (GTIM)
Not investment advice. All data without warranty, price as of 13.11.2026. Details in the risk notice.